3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial.
Academic Article
Publication Date:
2003
CRIS type:
1.1 Articolo in rivista
List of contributors:
Fontana, D; Mari, M; Martinelli, A; Boccafoschi, C; Magno, C; Turriziani, M; Maymone, Ss; COSCIANI CUNICO, Sergio; Zanollo, A; Montagna, G; Frongia, M; Jacobellis, U.
Published in: